Potential flaws and biases in a randomized controlled trial (RCT) of insulin determir vs. insulin glargine by Pieber and colleagues. [electronic resource]
- Diabetic medicine : a journal of the British Diabetic Association Jan 2008
- 115-6 p. digital
Publication Type: Comment; Comparative Study; Letter
1464-5491
10.1111/j.1464-5491.2007.02335.x doi
Blood Glucose Diabetes Mellitus, Type 1--drug therapy Humans Hypoglycemic Agents--therapeutic use Insulin--analogs & derivatives Insulin Detemir Insulin Glargine Insulin, Long-Acting Randomized Controlled Trials as Topic Treatment Outcome